The University of Minnesota has begun a clinical study to test whether a novel cell therapy currently under clinical investigation as a treatment for acute myeloid leukemia and lymphoma can be effective as a treatment for COVID-19.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe